Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Pygbem1/Cya
Common Name:
Pygb-KO
Product ID:
S-KO-00733
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Pygb-KO
Strain ID
KOCMP-110078-Pygb-B6J-VA
Gene Name
Pygb
Product ID
S-KO-00733
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
110078
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:97828
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Pygbem1/Cya mice (Catalog S-KO-00733) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000045441
NCBI RefSeq
NM_153781
Target Region
Exon 2~3
Size of Effective Region
~4.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
PYGB, also known as brain-type glycogen phosphorylase (GP), is the rate-limiting enzyme of glycogen catabolism [2]. It plays a crucial role in glycogen metabolism, a form of essential metabolic reprogramming in cells. By breaking down glycogen, PYGB releases glucose-6-phosphate (G6P), which can then enter glycolysis or other metabolic pathways, thus influencing energy metabolism in cells.

In various diseases, PYGB has been found to be significantly involved. In cholangiocarcinoma (CCA), PYGB is upregulated in tissues and promotes carcinogenesis and cell proliferation. Hypoxia stimulates its activity in a phosphoglycerate kinase 1-dependent manner, facilitating aerobic glycolysis [1]. In non-small cell lung cancer (NSCLC), PYGB expression is positively related to TNM stage and lymph node metastasis. Overexpression promotes cell proliferation, migration, and invasion by activating the Wnt-β-catenin signaling pathway [3]. Similar findings are seen in gastric cancer, where PYGB depletion suppresses tumor growth and metastasis via the Wnt/β-catenin pathway [5]. In esophageal squamous carcinoma, androgen receptor-targeted PYGB contributes to tumor progression and metabolic reprogramming [4]. In pancreatic cancer, high expression of PYGB promotes cell proliferation, invasion, and metastasis, and it may be a novel diagnostic biomarker and gene therapy target [7]. In osteosarcoma cell lines, knockdown of PYGB inhibits cell proliferation, invasion, and migration [6].

In conclusion, PYGB is essential for glycogen metabolism and energy supply in cells. Through gene-knockdown or KO-like experiments in cell lines and animal models, it has been shown to play a promoting role in the progression of multiple cancers, including CCA, NSCLC, gastric cancer, esophageal squamous carcinoma, pancreatic cancer, and osteosarcoma. Understanding the function of PYGB in these disease conditions provides potential therapeutic targets for treating these cancers.

References:

1. Pan, Yani, Zhou, Yue, Shen, Yonghua, Wang, Zhangding, Wang, Lei. . Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression. In Cancer research, 84, 3803-3817. doi:10.1158/0008-5472.CAN-24-0088. https://pubmed.ncbi.nlm.nih.gov/39163511/

2. Yang, Caiting, Wang, Haojun, Shao, Miaomiao, Cai, Qianqian, Wu, Changxin. 2024. Brain-Type Glycogen Phosphorylase (PYGB) in the Pathologies of Diseases: A Systematic Review. In Cells, 13, . doi:10.3390/cells13030289. https://pubmed.ncbi.nlm.nih.gov/38334681/

3. Xiao, Lina, Wang, Wei, Huangfu, Qiuqiang, Tao, Hongjie, Zhang, Jingyi. 2020. PYGB facilitates cell proliferation and invasiveness in non-small cell lung cancer by activating the Wnt-β-catenin signaling pathway. In Biochemistry and cell biology = Biochimie et biologie cellulaire, 98, 565-574. doi:10.1139/bcb-2019-0445. https://pubmed.ncbi.nlm.nih.gov/32191839/

4. Miao, Huikai, Xu, Chunmei, Gao, Wuyou, Ren, Qiannan, Chen, Youfang. 2024. PYGB targeted by androgen receptor contributes to tumor progression and metabolic reprogramming in esophageal squamous carcinoma. In Cellular signalling, 124, 111481. doi:10.1016/j.cellsig.2024.111481. https://pubmed.ncbi.nlm.nih.gov/39442902/

5. Xia, Boning, Zhang, Ke, Liu, Chang. . PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer. In Technology in cancer research & treatment, 19, 1533033820926592. doi:10.1177/1533033820926592. https://pubmed.ncbi.nlm.nih.gov/32462986/

6. Zhang, Shuwei, Zhou, Yichi, Zha, Yuanyu, Li, Jingfeng, Jin, Wei. 2018. PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines. In Molecular medicine reports, 18, 715-722. doi:10.3892/mmr.2018.9022. https://pubmed.ncbi.nlm.nih.gov/29845265/

7. Ren, Li-Kun, Lu, Ri-Shang, Fei, Xiao-Bin, Wang, Xing, Pan, Yao-Zhen. 2024. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target. In Journal of cancer research and clinical oncology, 150, 127. doi:10.1007/s00432-024-05644-2. https://pubmed.ncbi.nlm.nih.gov/38483604/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest